| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00134-004-2303-8 |
| P698 | PubMed publication ID | 15127191 |
| P2093 | author name string | Peter Wilson | |
| Jane C Davies | |||
| Mark J Peters | |||
| Nigel J Klein | |||
| Katy J Fidler | |||
| Malcolm W Turner | |||
| P2860 | cites work | Association of low levels of mannan-binding protein with a common defect of opsonisation | Q69376492 |
| Sepsis and organ failure definitions and guidelines | Q70490976 | ||
| The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation | Q71071247 | ||
| Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype | Q71739931 | ||
| Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 Mr component of the Clq receptor | Q71800454 | ||
| Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene | Q71960083 | ||
| Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care | Q73152645 | ||
| Mannose-binding lectin alleles in a prospectively recruited UK population. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood | Q73422613 | ||
| Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study | Q74446395 | ||
| Association between deficiency of mannose-binding lectin and severe infections after chemotherapy | Q74446408 | ||
| Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B | Q74615697 | ||
| Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 | ||
| Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
| Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
| Intensive insulin therapy in critically ill patients | Q29618795 | ||
| The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine | Q29618869 | ||
| Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? | Q33724799 | ||
| Mannan-binding lectin enhances susceptibility to visceral leishmaniasis | Q34008749 | ||
| Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock | Q34145159 | ||
| Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome | Q34303866 | ||
| Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series | Q36244208 | ||
| The human mannose-binding protein functions as an opsonin | Q36356275 | ||
| A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis | Q40949167 | ||
| Mannose-binding lectin: the pluripotent molecule of the innate immune system | Q41265798 | ||
| Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury | Q43740164 | ||
| Continuing challenges of sepsis research | Q43763984 | ||
| Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics | Q43953062 | ||
| Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein | Q46487298 | ||
| Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians | Q46733770 | ||
| Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome | Q47410256 | ||
| Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome | Q47567531 | ||
| Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America | Q48021769 | ||
| Development of a pediatric multiple organ dysfunction score: use of two strategies. | Q52173974 | ||
| Genetics of critical illness: methodological issues. | Q54393441 | ||
| Acute Respiratory Tract Infections and Mannose-Binding Lectin Insufficiency During Early Childhood | Q57231109 | ||
| Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease | Q63728090 | ||
| P433 | issue | 7 | |
| P921 | main subject | inflammation | Q101991 |
| systemic inflammatory response syndrome | Q776030 | ||
| P304 | page(s) | 1438-1445 | |
| P577 | publication date | 2004-05-04 | |
| P1433 | published in | Intensive Care Medicine | Q15749164 |
| P1476 | title | Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin | |
| P478 | volume | 30 |
| Q28382803 | A pilot study of host genetic variants associated with influenza-associated deaths among children and young adults |
| Q37356668 | An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1-related disease in children |
| Q57316578 | Angiotensin-converting enzyme D allele does not influence susceptibility to acute hypoxic respiratory failure in children |
| Q40710446 | Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation |
| Q33612684 | Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis |
| Q35085251 | Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure |
| Q36196922 | Clinical manifestations of mannan-binding lectin deficiency |
| Q57237941 | Current Concepts of Severe Pneumococcal Community-acquired Pneumonia |
| Q30425921 | Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children |
| Q82437639 | Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children |
| Q48376508 | Entropy is more resistant to artifacts than bispectral index in brain-dead organ donors |
| Q35165707 | Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS |
| Q35907216 | Genetic Susceptibility to Sepsis: A Possible Role for Mannose-binding Lectin |
| Q36645151 | Genetic epidemiology of acute respiratory distress syndrome: implications for future prevention and treatment |
| Q33569219 | Genetic polymorphisms associated with acute lung injury |
| Q57416706 | Genetic polymorphisms in the endotoxin receptor may influence platelet count as part of the acute phase response in critically ill children |
| Q38164341 | If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it? |
| Q34400562 | Impact of mannose-binding lectin deficiency on radiocontrast-induced renal dysfunction: a post-hoc analysis of a multicenter randomized controlled trial |
| Q84975018 | Innate immune genetic profile to predict infection risk and outcome after liver transplant |
| Q98576866 | Levels of mannose-binding lectin (MBL) associates with sepsis-related in-hospital mortality in women |
| Q80824122 | Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis |
| Q40073077 | Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection |
| Q36402570 | Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk |
| Q92504014 | Mannan-Binding Lectin Regulates Inflammatory Cytokine Production, Proliferation, and Cytotoxicity of Human Peripheral Natural Killer Cells |
| Q79740876 | Mannan-binding lectin is a determinant of survival in infective endocarditis |
| Q40461306 | Mannose-Binding Lectin Levels in Critically Ill Children With Severe Infections. |
| Q40145824 | Mannose-Binding Lectin-Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection-Related Mortality After Liver Transplantation. |
| Q37633125 | Mannose-Binding Lectin: Biologic Characteristics and Role in the Susceptibility to Infections and Ischemia-Reperfusion Related Injury in Critically Ill Neonates. |
| Q83849211 | Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients |
| Q43804629 | Mannose-binding lectin and pulmonary morbidity in premature infants |
| Q41912063 | Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis |
| Q43555654 | Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells |
| Q28743387 | Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients |
| Q47281096 | Mannose-binding lectin deficiency provides a genetic basis for the use of SIRS/sepsis definitions in critically ill patients |
| Q40097728 | Mannose-binding lectin in HIV infection |
| Q34562723 | Mannose-binding lectin in innate immunity: past, present and future |
| Q50662698 | Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. |
| Q34032256 | Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation |
| Q87048438 | Mannose-binding lectin polymorphisms and the risk of sepsis: evidence from a meta-analysis |
| Q43892732 | Mannose-binding lectin serum levels in neonatal sepsis and septic shock |
| Q28267664 | Mannose-binding lectin: biology and clinical implications |
| Q34049577 | Mouse mannose-binding lectin-A and ficolin-A inhibit lipopolysaccharide-mediated pro-inflammatory responses on mast cells |
| Q34699496 | New insights of an old defense system: structure, function, and clinical relevance of the complement system |
| Q89947833 | No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus |
| Q80314024 | Phase I safety, tolerability, and pharmacokinetic study of recombinant human mannan-binding lectin |
| Q34956291 | Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome |
| Q82437614 | Searching for the etiology of systemic inflammatory response syndrome: is SIRS occult endotoxemia? |
| Q54258179 | Serial Changes in Mannose-Binding Lectin in Patients with Sepsis. |
| Q35006249 | Significance of mannose-binding lectin deficiency and nucleotide-binding oligomerization domain 2 polymorphisms in Staphylococcus aureus bloodstream infections: a case-control study |
| Q36161359 | Susceptibility to infection in patients with neutropenia: the role of the innate immune system. |
| Q92364779 | Targeting the complement system in bacterial meningitis |
| Q36016375 | The developing human preterm neonatal immune system: a case for more research in this area. |
| Q26851880 | The role of mannose-binding lectin in severe sepsis and septic shock |
| Q36291716 | The role of the mannose-binding lectin in innate immunity |
| Q36047216 | Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, ex |
Search more.